CareRx Reports Voting Results from Annual General Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - CareRx Corporation (TSX: CRRX) (the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today announced that the nominees listed in the Management Information Circular for the Annual General Meeting of Shareholders held on May 28, 2026 (the "Meeting"), were elected as directors of the Company. In addition, all other resolutions put to vote at the Meeting were passe
2026-05-28 4:15 PM EDT | CareRx Corporation
NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance
Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle free drug delivery, today announced the filing of a new patent application (Reference No. P105204NL) covering a new fluid injection technology designed to optimize pressure profiles in needle-free drug delivery systems. The new technology enables a controlled, multi-phase injection profile that delivers the high pressure needed for reli
Healthcare and Hospitals, Pharmaceuticals, Health
2026-05-28 1:43 PM EDT | NuGen Medical Devices Inc.
WELL Health Announces Appointment of Healthcare Executive Derek Clark as Chief Operating Officer
Vancouver, British Columbia--(Newsfi
Technology, Computer Software, Healthcare and Hospitals, Health
2026-05-27 7:00 AM EDT | WELL Health Technologies Corp.
Adia Nutrition Announces Expanded Stem Cell Coverage Through Independent Monthly-Membership Health Care Sharing Ministry
Winter Park, Florida--(Newsfile Corp. - May 26, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine and innovative healthcare solutions, today announced that an independent monthly-membership health care sharing ministry — where members pay monthly dues as an alternative to traditional health insurance — now accepts up to three stem cell treatments per client. This expanded coverage provides eligible members with gre
Healthcare and Hospitals, Health
2026-05-26 8:00 AM EDT | Adia Nutrition Inc.
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
King of Prussia, Pennsylvania--(Newsfile Corp. - May 26, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today that Robert Bitterman, CEO and Chairman of the Board, will present an overview of the Company's INTASYL® siRNA platform, including its lead clinical candidate PH-762
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-05-26 7:00 AM EDT | Phio Pharmaceuticals Corp.
Discovery Senior Living Certified a Great Place to Work for Fifth Consecutive Year with Strong Employee Engagement and Culture-Driven Performance
Bonita Springs, Florida--(Newsfile Corp. - May 21, 2026) - Discovery Senior Living ("Discovery" or "the Company") and its affiliated companies, one of the nation's largest senior housing operators, announced today that it has once again been officially Certified as a Great Place to Work®, marking the fifth consecutive year the Company has earned the prestigious recognition.
Healthcare and Hospitals, Real Estate, Housing
2026-05-21 2:34 PM EDT | Discovery Senior Living
Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"
Reno, Nevada--(Newsfile Corp. - May 21, 2026) - Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company"), a biotechnology company advancing tissue regeneration, announced it has officially commenced trading on the Nasdaq today under the ticker symbol "CNXU." The Company currently has 25,269,996 shares on an issued and outstanding basis and 35,238,222 shares on a fully diluted basis.
Healthcare and Hospitals, Pharmaceuticals, Health
2026-05-21 12:02 PM EDT | Conexeu Sciences Inc.
Veritas Association Management Team Member Denise Herdrich Receives Prestigious John Hinckley Outstanding Service Award
East Dundee, Illinois--(Newsfile Corp. - May 21, 2026) - Veritas Association Management announced that Denise Herdrich, associate director supporting the Society of Cardiovascular Anesthesiologists (SCA), has received the John Hinckley Outstanding Service Award, one of the Society's highest honors recognizing non-physician professionals who have advanced the field of cardiovascular anesthesiology through service and contributions to the specialty. Herdrich was recognized during the SCA
2026-05-21 9:18 AM EDT | Veritas Association Management
Adia Med Now Recruiting for Kidney Health and Lower Back Pain Studies Listed on ClinicalTrials.gov
Winter Park, Florida--(Newsfile Corp. - May 20, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine, today announced that its subsidiary Adia Med of Winter Park LLC is now actively recruiting participants for two key clinical studies officially listed as "Recruiting" on ClinicalTrials.gov.
Healthcare and Hospitals, Health
2026-05-20 11:58 AM EDT | Adia Nutrition Inc.
Theralase(R) Closes C$4.8 Million Offering
Toronto, Ontario--(Newsfile Corp. - May 20, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria and viruses is pleased to announce that it has closed its previously announced brokered private placement offering ("Brokered Offering
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2026-05-20 11:06 AM EDT | Theralase Technologies Inc.
Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology
White Bear Lake, Minnesota--(Newsfile Corp. - May 20, 2026) - Envoy Medical® Inc. (NASDAQ: COCH), a hearing health company pioneering fully implanted hearing solutions, today announced the issuance of multiple patents across Australia and Europe, as well as the upcoming grant of an additional European patent, further expanding the Company's intellectual property portfolio and reinforcing its position in the cochlear implant i
Biotechnology, Healthcare and Hospitals
2026-05-20 8:30 AM EDT | Envoy Medical, Inc.
Sym Sciences Awarded $50,000 Grant to Advance IND-Ready Cannabinoid Research Platform
New York, New York--(Newsfile Corp. - May 20, 2026) - Sym Sciences announced today that it has been awarded a $50,000 grant from the to support the development of standardized, IND-ready cannabinoid materials for clinical research. The funding will enable Sym Sciences to expand its university research network and accelerate the preparation of regulatory-grade cannabinoid formulations designed for NIH-funded studies. The initiative is focused on streamlining the pathway from product deve
Healthcare and Hospitals, Pharmaceuticals, Health
2026-05-20 8:25 AM EDT | Sym Sciences
Resverlogix Closes US$2 Million Shares-for-Interest Private Placement
Calgary, Alberta--(Newsfile Corp. - May 19, 2026) - Resverlogix Corp. (TSX: RVX) ("Resverlogix") announced today that it has closed a $2,760,057 (US$2,000,000) shares-for-interest private placement (the "Transaction") with an arm's length subscriber (the "Subscriber"). Under the terms of the Transaction, the Subscriber subscribed for 26,864,133 common shares at CAD$0.103 per share, equal to the applicable 5-day volume-weighted average price, for aggregate proceeds of CAD$2,760,057 (US
Technology, Biotechnology, Healthcare and Hospitals
2026-05-19 5:15 PM EDT | Resverlogix Corp.
Richards Group Inc. Announces May 2026 Dividend
Toronto, Ontario--(Newsfile Corp. - May 19, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") announced today its cash dividend for the month ended May 31, 2026 of Cdn$0.11 per share. This dividend will be to shareholders of record at the close of business on May 29, 2026 and will be payable on June 12, 2026. Shareholders who are non-residents of Canada may be required to pay all withholding taxes payable in respect of any dividends of income by the Company, whether such dividends are
Healthcare and Hospitals, Household / Consumer / Cosmetics, Pharmaceuticals
2026-05-19 9:48 AM EDT | Richards Group Inc.
NorthPalm Capital Launches as AI-Augmented Investment Company
Toronto, Ontario--(Newsfile Corp. - May 19, 2026) - NorthPalm Capital Corp. (CSE: NP) ("NorthPalm" or the "Company") is pleased to announce the launch of NorthPalm Capital[1], an AI-augmented investment company focused on identifying and supporting high-growth opportunities across technology and digital asset sectors. The launch reflects NorthPalm's evolution into a leaner, high-conviction investment company with a modern approach to sourcing, evaluating, and act
Biotechnology, Healthcare and Hospitals, Health
2026-05-19 8:36 AM EDT | NorthPalm Capital Corp.
Conexeu Sciences Advances 3D Biofabricated Matrix to Move Breast Reconstruction Beyond Implants
Reno, Nevada--(Newsfile Corp. - May 19, 2026) -
Healthcare and Hospitals, Pharmaceuticals, Health
2026-05-19 8:30 AM EDT | Conexeu Sciences Inc.
WELL Health Announces Approval of Normal Course Issuer Bid
Vancouver, British Columbia--(Newsfile Corp. - May 19, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that the Notice of Intention to Make a Normal Course Issuer Bid ("NCIB") it filed with the Toronto Stock Exchange ("TSX") has been appr
Technology, Computer Software, Healthcare and Hospitals, Health
2026-05-19 7:00 AM EDT | WELL Health Technologies Corp.
Cosmo Announces Completion of Phase II Enrolment in Distal Ulcerative Colitis Program
Dublin, Ireland--(Newsfile Corp. - May 18, 2026) - Cosmo N.V. (SIX: COPN) (XETRA: C43) (“Cosmo” or “the Company”) today announced the completion of patient enrolment in its Phase II clinical trial (EUCT number: 2023-506917-23-00) evaluating its novel investigational therapy, Rifamycin enema, for the treatment of distal ulcerative colitis (UC) and ulcerative proctitis. A total of 77 patients were enrolled at 24 clinical sites in Europe, reflecting strong
Healthcare and Hospitals, Health
2026-05-18 1:03 AM EDT | Cosmo Pharmaceuticals N.V.
ADIA Nutrition, Inc. Reports Strong Revenue Growth and Operational Momentum for First Quarter 2026
Winter Park, Florida--(Newsfile Corp. - May 15, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a leader in advanced nutrition and regenerative health solutions, today announced its 3rd party reviewed financial results for the first quarter ended March 31, 2026, highlighting significant year-over-year revenue growth and continued expansion of its biologics and medical procedures segments.
Healthcare and Hospitals, Health
2026-05-15 7:59 AM EDT | Adia Nutrition Inc.
AllStar Global Brands Announces Strategic Partnership with Riccione Femminile Calcio
Ontario and Riccione, Italy--(Newsfile Corp. - May 14, 2026) - AllStar Global Brands (OTCID: ALST) ("ASGB") is pleased to announce that an agreement has been reached to acquire a 60% ownership stake in Riccione Femminile Calcio for €50,000, marking the beginning of a long-term strategic partnership focused on developing women's football and international player pathways. As part of the agreement, ASGB will provide financial assistance, operational support, and access to d
Healthcare and Hospitals, Retail, Health
2026-05-14 10:37 AM EDT | Allstar Health Brands, Inc.